MINERVA BIOTECHNOLOGIES Corp — Form D

MINERVA BIOTECHNOLOGIES Corp of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-05. The offering totals $8.0M, of which $4.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Ronald R AxelrodDirectorWaltham, MA
Cynthia BamdadDirectorWaltham, MA
James R BridgesDirectorWaltham, MA
Lawrence Anthony CoolidgeDirectorWaltham, MA
Kenneth KosikDirectorWaltham, MA
Joseph Anthony NathanDirectorWaltham, MA
Kenneth Anthony ReedDirectorWaltham, MA
Robert StaszewskiDirectorWaltham, MA
Cynthia BamdadExecutive OfficerWaltham, MA
Kenneth ReedDirectorWaltham, MA
Kenneth ReedRelated PersonWaltham, MA
Kenneth KosikRelated PersonWaltham, MA
Robert StaszewskiRelated PersonWaltham, MA
Joseph Anthony NathanRelated PersonWaltham, MA
Cynthia BamdadPromoterWaltham, MA
Cynthia BamdadRelated PersonWaltham, MA
James F BridgesDirectorWaltham, MA
Normand F SmithDirectorWaltham, MA
Normand S SmithDirectorWaltham, MA
Normand S SmithExecutive OfficerWaltham, MA
James S BridgesDirectorWaltham, MA
James BridgesRelated PersonWaltham, MA
Normand SmithDirectorBoston, MA
Normand F. SmithRelated PersonWaltham, MA
Lawrence CoolidgeRelated PersonWaltham, MA

Other filings by this issuer (9)

FiledFormOfferingSold
2023-01-04D/A$30.0M$328K
2022-02-23D$25.0M$125K
2022-01-28D/A$30.0M$24.1M
2019-10-30D$12.0M$1.5M
2019-04-05D$12.0M$4.2M
2018-10-02D$31.2M$29.3M
2014-10-24D$30.0M$2.0M
2010-11-17D$5.9M$4.6M
2010-02-23D$5.0M$1.6M

More